← Leaderboards
Clinton F Stewart
St. Jude Children'S Research Hospital
$6,135,444
Attributed
$6,135,444
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $433.5K · FY2006–23$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$6,135,444 · 5
By mechanism
P01$3,003,704 · 2
R01$2,128,363 · 1
P30$858,377 · 1
R21$145,000 · 1
Top collaborators
No co-investigators on record.
Most similar at St. Jude Children'S Research Hospital
Same institution · by research overlap
- Mary V. Relling$28,942,987
- William E. Evans$20,051,064
- Jun J. Yang$13,116,250
- Victor M Santana$4,139,851
- Daniel Savic$2,767,925
Others in their field
Top investigators on “Pharmacodynamics”
- Leonard Freedman · Leidos Biomedical Research, Inc.$239,520,687
- Richard L Schilsky · University Of Chicago$115,275,890
- David Heimbrook · Leidos Biomedical Research, Inc.$109,519,710
- Lynn Briscoe · Leidos Biomedical Research, Inc.$93,294,869
- Wafaa M. El-Sadr · Columbia University Health Sciences$91,263,426
- Myron S Cohen · Family Health International$91,263,426
Research focus
PharmacodynamicsDesignResponsePlasmaChildToxic EffectPharmacogeneticsPharmacodynamic ModelResearch PersonnelClinical TrialsDrug KineticsAntineoplastic AgentsPharmaceutical PreparationsPharmacologyMalignant Childhood NeoplasmTopotecanTissuesBaseClinical ResearchExposure ToRecommendationPre-Clinical ModelBiologicalKinase Inhibitor
Grant awards (20)
Pharmacokinetics Shared Resources Core$289,295
P30 · FY2023 · CA · contact PI
Pharmacokinetics Shared Resources Core$289,295
P30 · FY2022 · CA · contact PI
Pharmacokinetics Shared Resources Core$279,787
P30 · FY2021 · CA · contact PI
Anticancer Drug Pharmacology in Very Young Children$433,475
R01 · FY2016 · CA · contact PI
Anticancer Drug Pharmacology in Very Young Children$433,475
R01 · FY2015 · CA · contact PI
Anticancer Drug Pharmacology in Very Young Children$420,471
R01 · FY2014 · CA · contact PI
Anticancer Drug Pharmacology in Very Young Children$407,467
R01 · FY2013 · CA · contact PI
Anticancer Drug Pharmacology in Very Young Children$433,475
R01 · FY2012 · CA · contact PI
SOLID TUMOR PHARMACOLOGY CORE$310,826
P01 · FY2011 · CA · contact PI
SOLID TUMOR PHARMACOLOGY CORE$364,826
P01 · FY2010 · CA · contact PI
SOLID TUMOR PHARMACOLOGY CORE$357,797
P01 · FY2009 · CA · contact PI
SOLID TUMOR PHARMACOLOGY CORE$347,230
P01 · FY2008 · CA · contact PI
SOLID TUMOR PHARMACOLOGY CORE$312,641
P01 · FY2007 · CA · contact PI
CORE--SOLID TUMOR PHARMACOLOGY$285,821
P01 · FY2006 · CA · contact PI
CORE--SOLID TUMOR PHARMACOLOGY$285,821
P01 · FY2002 · CA
ABC TRANSPORTER IN CAMPTOTHECIN PHARMACOLOGY /PHYSIOLOGY$0
P01 · FY2002 · CA
CORE--SOLID TUMOR PHARMACOLOGY$285,821
P01 · FY2001 · CA
CORE--SOLID TUMOR PHARMACOLOGY$285,821
P01 · FY2001 · CA
CORE--SOLID TUMOR PHARMACOLOGY$167,100
P01 · FY2000 · CA
TRIALS OF CLADRIBINE PLUS OTHER AGENTS FOR PEDIATRIC AML$145,000
R21 · FY2000 · CA